PARD OTC
Poniard Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$28M
+34.9% ▲
Net Income
-$30M
+34.3% ▲
EPS (Diluted)
$-26.40
+49.6% ▲
EBITDA
-$25M
+35.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -100.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $2M | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $13M | $23M | $35M | $26M | $8M |
| SG&A Expenses | $8M | $12M | $13M | $15M | $17M |
| Operating Expenses | $21M | $35M | $49M | $43M | $28M |
| Operating Income | -$21M | -$35M | -$49M | -$43M | -$28M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $4M | $2M | $2M | $3M | $2M |
| Income Before Tax | $0 | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$23M | -$33M | -$49M | -$46M | -$30M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-54.80 | $-43.20 | $-56.40 | $-52.40 | $-26.40 |
| EBITDA | -$17M | -$30M | -$48M | -$39M | -$25M |
| Shares Outstanding | 434400 | 769050 | 867150 | 881800 | 1M |